72
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Thiazolidinediones are associated with a reduced risk of COPD exacerbations

, , , , , & show all
Pages 1591-1597 | Published online: 10 Aug 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Chin-Hsiao Tseng. (2022) Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 285-295.
Read now
Amir Tajbakhsh, Seyed Mohammad Gheibihayat, Deniz Mortazavi, Pourya Medhati, Behrouz Rostami, Amir Savardashtaki & Amir Abbas Momtazi-Borojeni. (2021) The Effect of Cigarette Smoke Exposure on Efferocytosis in Chronic Obstructive Pulmonary Disease; Molecular Mechanisms and Treatment Opportunities. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:6, pages 723-736.
Read now
John S. Tregoning & Patrick Mallia. (2019) Modulating airway glucose to reduce respiratory infections. Expert Review of Respiratory Medicine 13:2, pages 121-124.
Read now
Mario Cazzola, Paola Rogliani, Ermanno Puxeddu, Josuel Ora & Maria Gabriella Matera. (2018) An overview of the current management of chronic obstructive pulmonary disease: can we go beyond the GOLD recommendations?. Expert Review of Respiratory Medicine 12:1, pages 43-54.
Read now
Sowmya P Lakshmi, Aravind T Reddy & Raju C Reddy. (2017) Emerging pharmaceutical therapies for COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2141-2156.
Read now

Articles from other publishers (19)

Sachi Matsubayashi, Saburo Ito, Jun Araya & Kazuyoshi Kuwano. (2023) Drugs against metabolic diseases as potential senotherapeutics for aging-related respiratory diseases. Frontiers in Endocrinology 14.
Crossref
Sangmi S. Park, Jessica L. Perez Perez, Brais Perez Gandara, Christina W. Agudelo, Romy Rodriguez Ortega, Huma Ahmed, Itsaso Garcia-Arcos, Cormac McCarthy & Patrick Geraghty. (2022) Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?. Medicina 58:8, pages 1030.
Crossref
Serghei Covantsev, Olga Corlateanu, Stanislav I. Volkov, Rasul Uzdenov, Victor Botnaru & Alexandru Corlateanu. (2022) COPD and Diabetes Mellitus: Down the Rabbit Hole. Current Respiratory Medicine Reviews 18:2, pages 95-103.
Crossref
Amirhossein Fathinavid, Zaynab Mousavian, Ali Najafi, Sajjad Nematzadeh, Mahdieh Salimi & Ali Masoudi-Nejad. (2022) Identifying common signatures and potential therapeutic biomarkers in COPD and lung cancer using miRNA-mRNA co-expression networks. Informatics in Medicine Unlocked 34, pages 101115.
Crossref
Fu-Shun Yen, James Cheng-Chung Wei, Yu-Cih Yang, Chih-Cheng Hsu & Chii-Min Hwu. (2021) Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease. Frontiers in Medicine 8.
Crossref
Kuan-Yuan Chen, Sheng-Ming Wu, Chien-Hua Tseng, Kang-Yun Lee, Yu-Huei Lin, Hung-Yi Liu & Li-Nien Chien. (2021) Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case–control study. BMC Pulmonary Medicine 21:1.
Crossref
Nakwon Kwak, Kyoung-Hee Lee, Jisu Woo, Jiyeon Kim, Chang-Hoon Lee & Chul-Gyu Yoo. (2021) Synergistic cycles of protease activity and inflammation via PPARγ degradation in chronic obstructive pulmonary disease. Experimental & Molecular Medicine 53:5, pages 947-955.
Crossref
Meng-Ting Wang, Jyun-Heng Lai, Ya-Ling Huang, Feng-Chih Kuo, Yun-Han Wang, Chen-Liang Tsai & Min-Yu Tu. (2020) Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case–control study. Respiratory Research 21:1.
Crossref
Tasmania del Pino-Sedeño, Beatriz González de León, Elías Fernando Pérez Martín, Anna María Martín Gandolfo, Marcos Estupiñán Ramírez, Maximino Redondo, Yolanda Ramallo-Fariña & María M. Trujillo-Martín. (2020) Relationship between glycemic control and chronic obstructive pulmonary disease in patients with type 2 diabetes: A nested case-control study. Primary Care Diabetes 14:6, pages 729-735.
Crossref
Cuixue Wang, Jiedong Zhou, Jinquan Wang, Shujing Li, Atsushi Fukunaga, Junji Yodoi & Hai Tian. (2020) Progress in the mechanism and targeted drug therapy for COPD. Signal Transduction and Targeted Therapy 5:1.
Crossref
Chaitanya Mamillapalli, Ramesh Tentu, Nitesh Kumar Jain & Ramanath Bhandari. (2019) COPD and Type 2 Diabetes. Current Respiratory Medicine Reviews 15:2, pages 112-119.
Crossref
Simone Schierle, Cathrin Flauaus, Pascal Heitel, Sabine Willems, Jurema Schmidt, Astrid Kaiser, Lilia Weizel, Tamara Goebel, Astrid S. Kahnt, Gerd Geisslinger, Dieter Steinhilber, Mario Wurglics, G. Enrico Rovati, Achim Schmidtko, Ewgenij Proschak & Daniel Merk. (2018) Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology. Journal of Medicinal Chemistry 61:13, pages 5758-5764.
Crossref
Anne E. Dixon & Tatsiana Beiko. (2018) Bariatric Surgery to Prevent COPD Exacerbations?. Chest 153:3, pages 586-587.
Crossref
Emma H. Baker & Deborah L. Baines. (2018) Airway Glucose Homeostasis. Chest 153:2, pages 507-514.
Crossref
Mario Cazzola, Paola Rogliani, Luigino Calzetta, Davide Lauro, Clive Page & Maria Gabriella Matera. (2017) Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus. Trends in Pharmacological Sciences 38:10, pages 940-951.
Crossref
Annika Åstrand, Cecilia Wingren, Audra Benjamin, John S Tregoning, James P Garnett, Helen Groves, Simren Gill, Maria Orogo-Wenn, Anders J Lundqvist, Dafydd Walters, David M Smith, John D Taylor, Emma H Baker & Deborah L Baines. (2017) Dapagliflozin-lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice . British Journal of Pharmacology 174:9, pages 836-847.
Crossref
Chad H. Hochberg & Venkataramana K. Sidhaye. 2017. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease 165 184 .
Deborah L. Baines & Emma H. Baker. 2017. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease. Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease 33 57 .
Alexandru Corlateanu, Serghei Covantev, Alexander G. Mathioudakis, Victor Botnaru & Nikolaos Siafakas. (2016) Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease. Respiratory Investigation 54:6, pages 387-396.
Crossref